FDA Inspection 714537 — Pfizer, Inc.

Pfizer, Inc. — FEI 3003836868

The FDA completed an inspection of Pfizer, Inc. on Mar 11, 2011 in Parsippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 11, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Parsippany, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.